» Articles » PMID: 30474469

Breast Cancer-released Exosomes Trigger Cancer-associated Cachexia to Promote Tumor Progression

Overview
Journal Adipocyte
Date 2018 Nov 27
PMID 30474469
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

Cancer-secreted exosomes are emerging mediators of cancer-associated cachexia. Here, we show that miR-155 secreted by breast cancer cells is a potent role on the catabolism of adipocytes and muscle cells through targeting the PPARγ. After cocultivated with mature adipocytes or C2C12, tumour cells exhibit an aggressive phenotype via inducing epithelial-mesenchymal transition while breast cancer-derived exosomes increased catabolism and release the metabolites in adipocytes and muscle cells. In adipocytes, cancer cell-secreted miR-155 promotes beige/brown differentiation and remodel metabolism in resident adipocytes by downregulating the PPARγ expression, but does not significantly affect biological conversion in C2C12. Likewise, propranolol ameliorates tumour exosomes-associated cachectic wasting through upregulating the PPARγ expression. In summary, we have demonstrated that the transfer of miR-155 from exosomes acts as an oncogenic signal reprograming systemic energy metabolism and leading to cancer-associated cachexia in breast cancer.

Citing Articles

Contribution of tumor microenvironment (TME) to tumor apoptosis, angiogenesis, metastasis, and drug resistance.

Xiao Y, Hassani M, Moghaddam M, Fazilat A, Ojarudi M, Valilo M Med Oncol. 2025; 42(4):108.

PMID: 40087196 DOI: 10.1007/s12032-025-02675-8.


Myogenic microRNAs as Therapeutic Targets for Skeletal Muscle Mass Wasting in Breast Cancer Models.

Artigas-Arias M, Curi R, Marzuca-Nassr G Int J Mol Sci. 2024; 25(12).

PMID: 38928418 PMC: 11204047. DOI: 10.3390/ijms25126714.


MicroRNA Nano-Shuttles: Engineering Extracellular Vesicles as a Cutting-Edge Biotechnology Platform for Clinical Use in Therapeutics.

Menjivar N, Oropallo J, Gebremedhn S, Souza L, Gad A, Puttlitz C Biol Proced Online. 2024; 26(1):14.

PMID: 38773366 PMC: 11106895. DOI: 10.1186/s12575-024-00241-6.


Exosomes in the pathogenesis and treatment of cancer-related cachexia.

Ru Q, Chen L, Xu G, Wu Y J Transl Med. 2024; 22(1):408.

PMID: 38689293 PMC: 11062016. DOI: 10.1186/s12967-024-05201-y.


Polymorphism (rs1143634) and IL-1β Plasma Concentration as Predictors of Nutritional Disorders and Prognostic Factors in Multiple Myeloma Patients.

Mazurek M, Szudy-Szczyrek A, Homa-Mlak I, Hus M, Malecka-Massalska T, Mlak R Cancers (Basel). 2024; 16(7).

PMID: 38610941 PMC: 11011170. DOI: 10.3390/cancers16071263.


References
1.
Shen R, Wang Y, Wang C, Yin M, Liu H, Chen J . MiRNA-155 mediates TAM resistance by modulating SOCS6-STAT3 signalling pathway in breast cancer. Am J Transl Res. 2015; 7(10):2115-26. PMC: 4656789. View

2.
Kim S, Tang T, Abbott M, Viscarra J, Wang Y, Sul H . AMPK Phosphorylates Desnutrin/ATGL and Hormone-Sensitive Lipase To Regulate Lipolysis and Fatty Acid Oxidation within Adipose Tissue. Mol Cell Biol. 2016; 36(14):1961-76. PMC: 4936063. DOI: 10.1128/MCB.00244-16. View

3.
Pang W, Su J, Wang Y, Feng H, Dai X, Yuan Y . Pancreatic cancer-secreted miR-155 implicates in the conversion from normal fibroblasts to cancer-associated fibroblasts. Cancer Sci. 2015; 106(10):1362-9. PMC: 4638007. DOI: 10.1111/cas.12747. View

4.
Kim S, Lee E, Jung J, Lee J, Kim H, Kim J . microRNA-155 positively regulates glucose metabolism via PIK3R1-FOXO3a-cMYC axis in breast cancer. Oncogene. 2018; 37(22):2982-2991. PMC: 5978802. DOI: 10.1038/s41388-018-0124-4. View

5.
He W, Calore F, Londhe P, Canella A, Guttridge D, Croce C . Microvesicles containing miRNAs promote muscle cell death in cancer cachexia via TLR7. Proc Natl Acad Sci U S A. 2014; 111(12):4525-9. PMC: 3970508. DOI: 10.1073/pnas.1402714111. View